UK NHS grants HRA/REC approval for PEMP study with Peterborough and Cambridge hospitals Clinical observational study investigating underlying biology of endo...

Medix Biochemica's Board approved a $5 million investment to expand recombinant and cell culture antigen capabilities at its Espoo, Finland and St. Louis, Misso...

Ceremonial groundbreaking kicks off the first construction phase Pharmaceutical service provider advances its expansion with a 50,000 sqm facility Strateg...

Bellberry Human Research Ethics Committee (HREC) approves Neurizon's Phase 1 formulation study supporting development of the NUZ-001 oral liquid formulation and...

Romaciclib combined with venetoclax (VEN) shows encouraging anti-leukemic activity, including durable responses, in patients with relapsed/refractory acute myel...

Eliquis (apixaban) is on course for one of the largest single-asset revenue collapses in pharmaceutical history. Its sales are forecast to fall from $14.4 billio...

Denmark has a strong digital infrastructure, but the implementation and commercialisation of artificial intelligence in Danish companies is lagging behind. A new...

AOP Health, a global pharmaceutical enterprise group focused on integrated therapies for rare diseases and critical care, today announced a strategic partnership...

First investigational inhaled ENaC blocker to deliver clinically relevant and statistically significant change in lung function compared to placebo Inhaled t...

Rapid binder triage, of AI-driven candidate sets, enables early elimination of non-binders ahead of costly downstream workflows Powered by cell-free technolo...